Laddar...
Trastuzumab: updated mechanisms of action and resistance in breast cancer
HER2-postitive breast cancer has the second-poorest prognosis among breast cancer subtypes. One of the most effective targeted therapies for patients with HER2-positive breast cancer is trastuzumab-based. However, primary or acquired resistance to trastuzumab has been a major obstacle in the clinica...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2012-06-01
|
| Serie: | Frontiers in Oncology |
| Ämnen: | |
| Länkar: | http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00062/full |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|